Cargando…
Arhgef15 Promotes Retinal Angiogenesis by Mediating VEGF-Induced Cdc42 Activation and Potentiating RhoJ Inactivation in Endothelial Cells
BACKGROUND: Drugs inhibiting vascular endothelial growth factor (VEGF) signaling are globally administered to suppress deregulated angiogenesis in a variety of eye diseases. However, anti-VEGF therapy potentially affects the normal functions of retinal neurons and glias which constitutively express...
Autores principales: | Kusuhara, Sentaro, Fukushima, Yoko, Fukuhara, Shigetomo, Jakt, Lars Martin, Okada, Mitsuhiro, Shimizu, Yuri, Hata, Masayuki, Nishida, Kohji, Negi, Akira, Hirashima, Masanori, Mochizuki, Naoki, Nishikawa, Shin-Ichi, Uemura, Akiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448698/ https://www.ncbi.nlm.nih.gov/pubmed/23029280 http://dx.doi.org/10.1371/journal.pone.0045858 |
Ejemplares similares
-
A functional antagonism between RhoJ and Cdc42 regulates fibronectin remodelling during angiogenesis
por: Sundararaman, Ananthalakshmy, et al.
Publicado: (2020) -
Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis
por: Kim, Chan, et al.
Publicado: (2016) -
The Role of RhoJ in Endothelial Cell Biology and Tumor Pathology
por: Shi, Ting-Ting, et al.
Publicado: (2016) -
Oncogenic Gαq activates RhoJ through PDZ-RhoGEF
por: Cervantes-Villagrana, Rodolfo Daniel, et al.
Publicado: (2023) -
RHOJ controls EMT-associated resistance to chemotherapy
por: Debaugnies, Maud, et al.
Publicado: (2023)